Trial Profile

Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules With RotaTeq and Rotarix.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 19 Nov 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs RIX 4414 (Primary) ; Rotavirus W179-9 vaccine (Primary)
Indications Rotavirus infections
Focus Pharmacodynamics

Most Recent Events

07 Oct 2018 Results of a retrospective analysis assessing the impact of antibiotic exposure on serological responses to Rotavirus Vaccination (n=1174) presented at the IDWeek 2018
20 Sep 2013 Planned end date changed from 1 Aug 2014 to 1 Mar 2014 as reported by ClinicalTrials.gov.
20 Sep 2013 Planned end date changed from 1 Sep 2013 to 1 Aug 2014 as reported by ClinicalTrials.gov..

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com